RecruitingPhase 3NCT04267848Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])Sponsor: National Cancer Institute (NCI)Annapolis, MD · Baltimore, MD · +1147 more sites
RecruitingPhase 3NCT06498635Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialSponsor: National Cancer Institute (NCI)Aberdeen, MD · Baltimore, MD · Cumberland, MD · +278 more sites
RecruitingPhase 2NCT05642572Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)Sponsor: SWOG Cancer Research NetworkBaltimore, MD · Cumberland, MD · Gaithersburg, MD · +451 more sites
RecruitingPhase 2 / Phase 3NCT03851445Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerSponsor: SWOG Cancer Research NetworkAnnapolis, MD · Baltimore, MD · +1226 more sites